Key Metrics for Regeneron Pharmaceuticals Inc (REGN)

20 Years of financial data for all companies,
including key metrics, annual/quarterly financials, and historic PE ratio.



Please enter the stock ticker. Add .to for Canadian stocks.


Check items to have them appear in the chart below.

TTM 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31 2017-12-31 2016-12-31 2015-12-31 2014-12-31 2013-12-31 2012-12-31 2011-12-31 2010-12-31 2009-12-31 2008-12-31 2007-12-31 2006-12-31 2005-12-31 2004-12-31 2003-12-31
Per Share Items
Revenue Per Share 115.53 107.24 143.24 73.82 68.61 58.45 50.66 41.81 35.61 24.85 18.92 12.41 4.92 5.54 4.75 3.03 1.88 1.09 1.18 3.14 1.14
Net Income Per Share 35.21 38.22 71.97 30.52 18.46 21.29 10.34 7.70 5.52 3.07 3.82 6.75 -2.45 -1.26 -0.85 -1.05 -1.59 -1.77 -1.71 0.75 -2.13
Operating Cashflow Per Share 46.08 44.18 63.11 22.74 21.20 19.12 11.28 12.78 11.55 6.63 5.29 -0.67 -1.56 1.16 -0.91 -1.13 0.41 0.40 -0.54 -0.31 -0.12
Free Cash Flow Per Share 40.62 38.98 58.19 17.40 17.45 15.78 8.93 8.38 5.67 3.70 3.89 -1.12 -2.20 -0.04 -2.13 -1.57 0.13 0.35 -0.63 -0.42 -0.71
Cash Per Share 87.45 68.21 50.75 31.16 28.04 24.47 12.16 8.94 9.07 7.94 6.24 2.77 5.82 3.01 4.28 6.02 11.55 7.92 5.34 5.34 5.82
Book Value Per Share 219.69 199.66 167.27 95.78 96.76 76.27 53.01 38.27 31.72 22.41 17.55 11.21 5.36 6.36 4.97 5.31 6.94 3.74 2.04 3.29 2.73
Tangible Book Value Per Share 210.71 191.60 167.27 95.78 96.76 76.27 53.01 38.27 31.72 22.41 17.55 11.21 5.36 6.36 4.97 5.31 6.94 3.74 2.04 3.29 2.73
CAPEX Per Share -5.46 -5.20 -4.92 -5.34 -3.75 -3.34 -2.35 -4.40 -5.88 -2.93 -1.41 -0.44 -0.63 -1.20 -1.22 -0.44 -0.28 -0.05 -0.09 -0.11 -0.59
Shareholders Equity Per Share 219.69 199.66 167.27 95.78 96.76 76.27 53.01 38.27 31.72 22.41 17.55 11.21 5.36 6.36 4.97 5.31 6.94 3.74 2.04 3.29 2.73
Valuation Metrics
ROIC 0.14 0.16 0.34 0.21 0.15 0.24 0.15 0.16 0.13 0.10 0.17 0.44 -0.19 -0.11 -0.18 -0.35 -0.12 -0.21 -0.19 0.04 -0.29
ROE 0.17 0.19 0.43 0.32 0.19 0.28 0.20 0.20 0.17 0.14 0.22 0.60 -0.46 -0.20 -0.17 -0.20 -0.23 -0.47 -0.84 0.23 -0.78
Graham Number 417.16 414.37 520.45 256.46 200.47 191.15 111.05 81.45 62.76 39.33 38.82 41.28 17.18 13.43 9.75 11.20 15.76 12.18 8.84 7.47 11.43
Graham Net Net 71.66 56.29 40.39 12.97 19.29 18.21 5.46 -0.66 2.70 3.51 3.59 0.06 -2.50 -3.01 0.58 3.17 4.59 1.66 0.32 0.71 -0.63
Ratios
Price/Earnings 23.15 18.88 8.77 15.83 20.34 17.54 36.36 47.65 98.35 133.73 72.14 25.33 -22.65 -26.06 -28.44 -17.50 -15.17 -11.37 -9.32 12.24 -6.91
Price/Sales 6.67 6.73 4.41 6.54 5.47 6.39 7.42 8.78 15.24 16.51 14.54 13.78 11.27 5.93 5.09 6.07 12.81 18.34 13.44 2.93 12.91
Current Ratio 5.18 5.73 5.95 4.54 5.90 5.89 5.79 3.99 4.45 4.04 8.59 13.67 2.27 11.80 4.55 6.23 2.81 10.44 8.46 10.08 4.39
Price/Book 3.71 3.61 3.78 5.04 3.88 4.90 7.09 9.59 17.12 18.31 15.68 15.26 10.34 5.16 4.86 3.46 3.48 5.37 7.80 2.80 5.39
Enterprise Value/Sales 6.71 6.69 4.40 6.60 5.36 6.28 7.40 8.77 15.14 16.44 14.53 13.95 11.16 6.03 4.54 5.05 10.44 17.74 13.67 3.50 14.57
Debt/Equity 0.11 0.15 0.18 0.39 0.06 0.07 0.19 0.14 0.23 0.32 0.26 0.37 0.90 0.30 0.00 -0.38 0.44 0.82 1.55 0.99 1.55
Debt/Assets 0.08 0.12 0.13 0.25 0.05 0.05 0.13 0.09 0.15 0.21 0.17 0.22 0.33 0.15 0.00 -0.23 0.22 0.31 0.42 0.38 0.45